Ge Y, Romley J, Pacula R
Milbank Q. 2024; 102(3):669-691.
PMID: 38966909
PMC: 11576589.
DOI: 10.1111/1468-0009.12710.
Nardi W, Kelly P, Roy A, Becker S, Brewer J, Sun S
J Subst Use Addict Treat. 2024; 165:209442.
PMID: 38889880
PMC: 11347123.
DOI: 10.1016/j.josat.2024.209442.
Fernandez S, Miranda J, Pascual Pastor F, Munoz F
Arch Womens Ment Health. 2023; 26(5):639-650.
PMID: 37540344
PMC: 10491505.
DOI: 10.1007/s00737-023-01353-w.
Chetty A, Guse T, Malema M
Health SA. 2023; 28:2094.
PMID: 37151615
PMC: 10157410.
DOI: 10.4102/hsag.v28i0.2094.
Glover-Wright C, Coupe K, Campbell A, Keen C, Lawrence P, Kinner S
Drug Alcohol Rev. 2023; 42(5):1195-1219.
PMID: 37015828
PMC: 10946517.
DOI: 10.1111/dar.13651.
Cocaine Use Disorder (CUD): Current Clinical Perspectives.
Schwartz E, Wolkowicz N, Aquino J, MacLean R, Sofuoglu M
Subst Abuse Rehabil. 2022; 13:25-46.
PMID: 36093428
PMC: 9451050.
DOI: 10.2147/SAR.S337338.
Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis.
Bouchard M, Lecomte T, Cloutier B, Herrera-Roberge J, Potvin S
Front Psychiatry. 2022; 13:842329.
PMID: 35633799
PMC: 9133375.
DOI: 10.3389/fpsyt.2022.842329.
A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.
Clark A, Goodwin S, Marks R, Belcher A, Heinlein E, Bennett M
J Dual Diagn. 2021; 17(4):313-332.
PMID: 34582313
PMC: 9487392.
DOI: 10.1080/15504263.2021.1965407.
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study.
Kast K, Rao V, Wilens T
J Clin Psychiatry. 2021; 82(2).
PMID: 33988929
PMC: 8351325.
DOI: 10.4088/JCP.20m13598.
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
Gorman I, Nielson E, Molinar A, Cassidy K, Sabbagh J
Front Psychol. 2021; 12:645246.
PMID: 33796055
PMC: 8008322.
DOI: 10.3389/fpsyg.2021.645246.
Psychosocial interventions for people with both severe mental illness and substance misuse.
Hunt G, Siegfried N, Morley K, Brooke-Sumner C, Cleary M
Cochrane Database Syst Rev. 2019; 12:CD001088.
PMID: 31829430
PMC: 6906736.
DOI: 10.1002/14651858.CD001088.pub4.
Recommendations for increasing research on co-occurring serious mental illness and gambling problems.
Pullman R, Potenza M, Kraus S
J Behav Addict. 2018; 7(4):897-899.
PMID: 30418072
PMC: 6376370.
DOI: 10.1556/2006.7.2018.104.
Hidden Drug Abuse in Hong Kong: From Social Acquaintance to Social Isolation.
Tam C, Kwok S, Lo T, Lam S, Lee G
Front Psychiatry. 2018; 9:457.
PMID: 30319464
PMC: 6167475.
DOI: 10.3389/fpsyt.2018.00457.
Using NIATx strategies to implement integrated services in routine care: a study protocol.
Ford 2nd J, Osborne E, Assefa M, McIlvaine A, King A, Campbell K
BMC Health Serv Res. 2018; 18(1):431.
PMID: 29884164
PMC: 5994046.
DOI: 10.1186/s12913-018-3241-4.
Practical outpatient pharmacotherapy for alcohol use disorder.
Kim Y, Hack L, Ahn E, Kim J
Drugs Context. 2018; 7:212308.
PMID: 29445407
PMC: 5804871.
DOI: 10.7573/dic.212308.
Technology-Based Interventions for Substance Use and Comorbid Disorders: An Examination of the Emerging Literature.
Sugarman D, Campbell A, Iles B, Greenfield S
Harv Rev Psychiatry. 2017; 25(3):123-134.
PMID: 28475504
PMC: 5421396.
DOI: 10.1097/HRP.0000000000000148.
Factors Associated With Outpatient Visit Attendance After Discharge From Inpatient Psychiatric Units in a New York City Hospital.
Humensky J, Fattal O, Feit R, Mills S, Lewis-Fernandez R
Psychiatr Serv. 2017; 68(6):624-627.
PMID: 28196463
PMC: 5481167.
DOI: 10.1176/appi.ps.201600150.
From Clozapine to Cognitive Remediation.
Quinn J, Kolla N
Can J Psychiatry. 2016; 62(2):94-101.
PMID: 27335156
PMC: 5298523.
DOI: 10.1177/0706743716656830.
Nicotine dependence in the mental disorders, relationship with clinical indicators, and the meaning for the user.
Marques de Oliveira R, Siqueira Junior A, Santos J, Furegato A
Rev Lat Am Enfermagem. 2014; 22(4):685-92.
PMID: 25296154
PMC: 4292645.
DOI: 10.1590/0104-1169.3549.2468.
The influence of treatment attendance on subsequent aggression among severely mentally ill substance abusers.
Zhuo Y, Bradizza C, Maisto S
J Subst Abuse Treat. 2014; 47(5):353-61.
PMID: 25124261
PMC: 4175049.
DOI: 10.1016/j.jsat.2014.06.010.